<?xml version="1.0" encoding="UTF-8"?>
<ref id="B28-marinedrugs-17-00567">
 <label>28.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ferir</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Huskens</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Palmer</surname>
    <given-names>K.E.</given-names>
   </name>
   <name>
    <surname>Boudreaux</surname>
    <given-names>D.M.</given-names>
   </name>
   <name>
    <surname>Swanson</surname>
    <given-names>M.D.</given-names>
   </name>
   <name>
    <surname>Markovitz</surname>
    <given-names>D.M.</given-names>
   </name>
   <name>
    <surname>Balzarini</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Schols</surname>
    <given-names>D.</given-names>
   </name>
  </person-group>
  <article-title>Combinations of griffithsin with other carbohydrate-binding agents demonstrate superior activity against HIV type 1, HIV type 2, and selected carbohydrate-binding agent-resistant HIV type 1 strains</article-title>
  <source>AIDS Res. Hum. Retroviruses</source>
  <year>2012</year>
  <volume>28</volume>
  <fpage>1513</fpage>
  <lpage>1523</lpage>
  <pub-id pub-id-type="doi">10.1089/aid.2012.0026</pub-id>
  <pub-id pub-id-type="pmid">22607556</pub-id>
 </element-citation>
</ref>
